GE Healthcare
GE Healthcare is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Phase II, randomized, open-label, multi-center study of JSB462 in combination with lutetium (177Lu) vipivotide tetraxetan in adult male patients with PSMA-positive metastatic castration resistant prostate cancer (mCRPC)
Sponsor Novartis Pharma AG
- Start (EU)
- Latest update
- Estimated end
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer’s Disease
Sponsor F. Hoffmann-La Roche AG
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Dementia with Lewy Bodies (DLB)
Sponsor Eip Pharma Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for GE Healthcare?
The 2026-10-09 snapshot links GE Healthcare to 3 distinct CTIS trials. Recorded services include DaTscan Isotope, Radiolabelling of Locametz with radioactive gallium (68Ga), Radiolabelling of Locametz with radioactive gallium (68Ga) Ga), Third party Tracer Management (Amyloid PET) (Flutemetamol (Vizamyl) ). These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for GE Healthcare?
The most frequently recorded therapeutic areas are Neurology, Solid Tumor Oncology, Urology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to GE Healthcare conducted?
The linked trials record locations in 8 countries, including Spain, Netherlands, Austria, Czechia, Germany. These are trial locations, not confirmed office locations or countries where GE Healthcare delivered services.
What can this page tell me about GE Healthcare's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 3 recorded name variants under GE Healthcare. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- GE Healthcare
- GE Healthcare B.V.
- GE Healthcare Limited